Paragon Capital Management LLC Merck & Co., Inc. Transaction History

Paragon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$70.42 - $80.13 $11,126 - $12,660	-158 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$63.36 - $87.82 $10,010 - $13,875	158 New	158 $12,000
Q3 2019 Oct 31, 2019	SELL	$76.08 - $82.93 $7,608 - $8,293	-100 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $8,171 - $9,546	-117 Reduced 53.92%	100 $8,000
Q1 2019 Apr 15, 2019	BUY	$69.58 - $79.36 $15,098 - $17,221	217 New	217 $18,000

3,831

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $291B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Paragon Capital Management LLC with notifications on news.